{"id":"fecal-transplantation","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal pain or cramping"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Flatulence or bloating"}]},"_chembl":{"chemblId":"CHEMBL6068500","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FMT introduces diverse microbial populations into the patient's gastrointestinal tract, reestablishing beneficial bacteria and restoring microbial diversity. This reconstitution of the microbiota helps restore normal intestinal barrier function, immune homeostasis, and metabolic processes that are disrupted in dysbiotic states. The restored microbiota competes with pathogenic organisms and produces short-chain fatty acids and other metabolites essential for gut health.","oneSentence":"Fecal microbiota transplantation restores a healthy gut microbiome by transferring bacterial communities from a healthy donor to a patient with dysbiosis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:20.924Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection (recurrent or refractory)"},{"name":"Inflammatory bowel disease (Crohn's disease, ulcerative colitis)"}]},"trialDetails":[{"nctId":"NCT06623461","phase":"PHASE2","title":"LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-04-07","conditions":"Melanoma","enrollment":128},{"nctId":"NCT06478602","phase":"PHASE3","title":"Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","status":"COMPLETED","sponsor":"Cristian Ichim","startDate":"2024-08-05","conditions":"Liver Cirrhosis","enrollment":19},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT06591013","phase":"NA","title":"Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Nationality in the Treatment of IBD","status":"COMPLETED","sponsor":"First Affiliated Hospital of Kunming Medical University","startDate":"2022-10-14","conditions":"Inflammatory Bowel Diseases","enrollment":80},{"nctId":"NCT04090346","phase":"PHASE4","title":"Fecal Microbiota Transplant","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2018-06-05","conditions":"Clostridium Difficile Infection","enrollment":24},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT05669846","phase":"PHASE2","title":"Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-08","conditions":"Non Small Cell Lung Cancer","enrollment":26},{"nctId":"NCT06290258","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-03-06","conditions":"Autism Spectrum Disorder, Gastrointestinal Diseases, Healthy","enrollment":60},{"nctId":"NCT04038619","phase":"PHASE1","title":"Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-01","conditions":"Colitis, Diarrhea, Malignant Genitourinary System Neoplasm","enrollment":40},{"nctId":"NCT04975217","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplants for the Treatment of Pancreatic Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-14","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":10},{"nctId":"NCT05998213","phase":"PHASE2","title":"Transfer of Feces in Ulcerative Colitis 2","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2020-06-12","conditions":"Ulcerative Colitis, Ulcerative Colitis Flare, Ulcerative Colitis Acute","enrollment":85},{"nctId":"NCT07486492","phase":"EARLY_PHASE1","title":"Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2026-03-31","conditions":"Colorectal Cancer Metastatic, Fecal Microbiota Transplantation","enrollment":10},{"nctId":"NCT05333471","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-08-08","conditions":"Chronic Granulomatous Disease-associated Colitis","enrollment":20},{"nctId":"NCT05174273","phase":"PHASE2, PHASE3","title":"Neurocognitive Effects of FMT in MDD Patients With and Without IBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valerie Taylor","startDate":"2022-04-06","conditions":"Major Depressive Disorder, Irritable Bowel Syndrome","enrollment":133},{"nctId":"NCT04759001","phase":"PHASE1, PHASE2","title":"FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-02-18","conditions":"Enterobacteriaceae Infections, Multi-antibiotic Resistance","enrollment":52},{"nctId":"NCT05739864","phase":"PHASE1, PHASE2","title":"Superdonor FMT in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Active Ulcerative Colitis","enrollment":42},{"nctId":"NCT06071312","phase":"PHASE1, PHASE2","title":"FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-09-23","conditions":"Clostridium Difficile, Ulcerative Colitis","enrollment":64},{"nctId":"NCT05739825","phase":"","title":"Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Clostridioides Difficile Infection Recurrence","enrollment":20},{"nctId":"NCT07481422","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2026-03-15","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":70},{"nctId":"NCT07134491","phase":"","title":"Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-13","conditions":"Antibody Mediated Rejection After Kidney Transplantation","enrollment":45},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT07235501","phase":"","title":"Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation","status":"NOT_YET_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-06-01","conditions":"Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":75},{"nctId":"NCT04829136","phase":"NA","title":"Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2022-06-22","conditions":"Hematopoietic and Lymphatic System Neoplasm","enrollment":30},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT03819296","phase":"PHASE1","title":"Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-21","conditions":"Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8","enrollment":800},{"nctId":"NCT07463248","phase":"PHASE2","title":"PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Wang Xin","startDate":"2026-03-05","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":64},{"nctId":"NCT07464483","phase":"NA","title":"Multi-omic Characterization of Pediatric and Adult Patients Undergoing Hematopoietic Stem Cell Transplantation and Advanced Cell Therapies","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2025-11-21","conditions":"Bone Marrow Replaced Via Transplant","enrollment":260},{"nctId":"NCT05067595","phase":"PHASE1","title":"Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-01-24","conditions":"Intestinal Graft Versus Host Disease","enrollment":72},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT03786900","phase":"","title":"Fecal Microbiota Transplantation (FMT): PRIM-DJ2727","status":"AVAILABLE","sponsor":"Herbert DuPont, MD","startDate":"","conditions":"Recurrent Clostridium Difficile Infection, Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection","enrollment":""},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07042438","phase":"PHASE2","title":"Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-02-11","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":56},{"nctId":"NCT06333795","phase":"NA","title":"Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2024-04-01","conditions":"Diarrhea, Systemic Sclerosis","enrollment":20},{"nctId":"NCT05917379","phase":"PHASE1, PHASE2","title":"The Efficacy and Safty of FMT in Patients With CID","status":"COMPLETED","sponsor":"Peking University Sixth Hospital","startDate":"2023-10-08","conditions":"Insomnia Chronic, Fecal Microbiota Transplantation, Sleep Disorder","enrollment":80},{"nctId":"NCT05740319","phase":"NA","title":"Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-06-10","conditions":"Irritable Bowel Syndrome","enrollment":102},{"nctId":"NCT07432984","phase":"PHASE2","title":"Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Se-Hoon Lee","startDate":"2026-04-30","conditions":"Non Small Cell Lung Cancer","enrollment":15},{"nctId":"NCT06461208","phase":"PHASE3","title":"A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis","status":"RECRUITING","sponsor":"King's College London","startDate":"2023-06-21","conditions":"Liver Cirrhosis","enrollment":300},{"nctId":"NCT06252948","phase":"","title":"Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-12-29","conditions":"Plasma Cell Disorders","enrollment":240},{"nctId":"NCT03562741","phase":"NA","title":"Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile","status":"RECRUITING","sponsor":"Krunal Patel","startDate":"2014-01-16","conditions":"Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection","enrollment":500},{"nctId":"NCT07421947","phase":"NA","title":"Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Zurich","startDate":"2026-04","conditions":"Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM)","enrollment":30},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT06058520","phase":"EARLY_PHASE1","title":"Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2023-10-01","conditions":"Hidradenitis Suppurativa","enrollment":16},{"nctId":"NCT03524352","phase":"PHASE3","title":"the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2020-03-12","conditions":"Pouchitis","enrollment":42},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":"Crohn Disease","enrollment":120},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":129},{"nctId":"NCT07401680","phase":"PHASE1","title":"Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-03-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection","enrollment":85},{"nctId":"NCT05664113","phase":"PHASE1","title":"Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-07-07","conditions":"Gastro-Intestinal Disorder","enrollment":10},{"nctId":"NCT03686202","phase":"PHASE2, PHASE3","title":"Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2018-11-30","conditions":"All Solid Tumors","enrollment":65},{"nctId":"NCT06603883","phase":"PHASE2, PHASE3","title":"Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-10-19","conditions":"Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","enrollment":60},{"nctId":"NCT07381374","phase":"NA","title":"Fecal Microbiota Transplantation in Children With ASD","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Children's Hospital","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":75},{"nctId":"NCT07386795","phase":"NA","title":"The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-02-01","conditions":"Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation","enrollment":19},{"nctId":"NCT07387952","phase":"NA","title":"The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation：a Pilot Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-30","conditions":"Constipation - Functional, Fecal Microbiota Transplantation (FMT), Chronic Constipation","enrollment":5},{"nctId":"NCT04690738","phase":"","title":"Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation","status":"SUSPENDED","sponsor":"Rush University Medical Center","startDate":"2020-08-17","conditions":"Exocrine Pancreatic Insufficiency, Weight Gain","enrollment":50},{"nctId":"NCT03594487","phase":"PHASE1","title":"Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","sponsor":"Jeffrey Gelfand","startDate":"2018-11-16","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":5},{"nctId":"NCT05327790","phase":"PHASE2","title":"LFMT vs Placebo in New Biologic Start for Ulcerative Colitis","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-06-03","conditions":"Ulcerative Colitis","enrollment":40},{"nctId":"NCT07017946","phase":"PHASE1, PHASE2","title":"Intestinal Microbiome Transplant in ALS","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-27","conditions":"Amyotrophic Lateral Sclerosis ALS","enrollment":20},{"nctId":"NCT07374094","phase":"","title":"Clostridioides Difficile: Understanding Responses and Treatment Effects","status":"RECRUITING","sponsor":"Umeå University","startDate":"2026-01-26","conditions":"Clostridioides Difficile Infection","enrollment":200},{"nctId":"NCT07371013","phase":"NA","title":"Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mother and Child, Warsaw, Poland","startDate":"2026-01","conditions":"Autism Spectrum Disorder, Gastrointestinal Symptoms","enrollment":20},{"nctId":"NCT07364617","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-02-01","conditions":"Graft vs Host Disease","enrollment":35},{"nctId":"NCT07143981","phase":"","title":"The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2026-01-15","conditions":"Anorexia Nervosa","enrollment":20},{"nctId":"NCT03325855","phase":"","title":"Fecal Microbiota Transplant National Registry","status":"RECRUITING","sponsor":"American Gastroenterological Association","startDate":"2017-09-20","conditions":"Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome","enrollment":4000},{"nctId":"NCT07356752","phase":"NA","title":"Prediction of Lung Transplant Outcome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hopital Foch","startDate":"2025-06-17","conditions":"Graft Dysfunction, Lung Transplantation, Chronic Lung Allograft Dysfunction (CLAD)","enrollment":4200},{"nctId":"NCT06649981","phase":"PHASE1","title":"Aging Resilience Through Microbiota Optimization and Regulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gonzalo Jorquera, PhD","startDate":"2025-01-10","conditions":"Resilience, Cognitive Function and Well-Being, Muscle Function, Handgrip Strength Test","enrollment":80},{"nctId":"NCT07348471","phase":"NA","title":"Fecal Microbiota Transplantation for the Treatment of ICU Delirium","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-02-01","conditions":"Delirium","enrollment":60},{"nctId":"NCT07342205","phase":"PHASE2, PHASE3","title":"A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation","status":"RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2025-12-10","conditions":"Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome","enrollment":60},{"nctId":"NCT07345403","phase":"","title":"GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-01-01","conditions":"Postoperative Delirium (POD), Postoperative Bleeding, Acute Kidney Injury","enrollment":3000},{"nctId":"NCT03483246","phase":"PHASE3","title":"Impact of Fecal Microbiota Transplantation in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-17","conditions":"Ulcerative Colitis","enrollment":150},{"nctId":"NCT07332260","phase":"PHASE1","title":"Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2026-01","conditions":"Alzheimer s Disease, Faecal Microbiota Transplantation (FMT)","enrollment":10},{"nctId":"NCT07335523","phase":"PHASE2","title":"Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Digestive Care, Inc.","startDate":"2026-03","conditions":"Steatorrhea","enrollment":30},{"nctId":"NCT06026371","phase":"PHASE2","title":"Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2023-12-12","conditions":"Acute Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm","enrollment":138},{"nctId":"NCT07331688","phase":"PHASE1, PHASE2","title":"CMTS0515-auWMT for Radiation Enteritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2025-12-08","conditions":"Radiation Enteritis","enrollment":60},{"nctId":"NCT07305090","phase":"","title":"Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2025-10-15","conditions":"Blood Cancer","enrollment":90},{"nctId":"NCT04444362","phase":"NA","title":"Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)","status":"ENROLLING_BY_INVITATION","sponsor":"Nanjing Medical University","startDate":"2025-01-01","conditions":"Cardiovascular Disease, Cardiopulmonary Bypass","enrollment":500},{"nctId":"NCT07319364","phase":"PHASE1","title":"A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms, Antineoplastic Agents","enrollment":90},{"nctId":"NCT06801665","phase":"PHASE2","title":"FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis","status":"RECRUITING","sponsor":"Hua Jiang","startDate":"2025-04-17","conditions":"Colon Cancer Liver Metastases","enrollment":30},{"nctId":"NCT05598112","phase":"EARLY_PHASE1","title":"Effect of Gut Microbiome Intervention on Aging Via Oral FMT","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-04-24","conditions":"Aging, Frailty","enrollment":210},{"nctId":"NCT03420482","phase":"PHASE2","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-04-01","conditions":"Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT04745221","phase":"NA","title":"Efficacy and Safety of Auto-FMT in Preventing aGVHD","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-03-01","conditions":"Graft Versus Host Disease, Acute","enrollment":100},{"nctId":"NCT07247786","phase":"PHASE2","title":"Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)","status":"NOT_YET_RECRUITING","sponsor":"Fundación GECP","startDate":"2026-03-15","conditions":"Non Small Cell Lung Cancer, Respiratory Tract Neoplasm","enrollment":68},{"nctId":"NCT07276464","phase":"","title":"Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Health.","status":"RECRUITING","sponsor":"University of Rennes 2","startDate":"2025-11-17","conditions":"Healthy","enrollment":30},{"nctId":"NCT04729322","phase":"PHASE2","title":"Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-22","conditions":"Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8","enrollment":15},{"nctId":"NCT07292142","phase":"PHASE1, PHASE2","title":"FMT in Triple Negative Breast Cancer Guided by ctDNA","status":"NOT_YET_RECRUITING","sponsor":"Jewish General Hospital","startDate":"2026-02","conditions":"Breast Cancer","enrollment":125},{"nctId":"NCT07106580","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2025-07-28","conditions":"Colonization, Asymptomatic","enrollment":48},{"nctId":"NCT03407833","phase":"","title":"Physiologic and Functional Adaptations of Insulin Sensitive Tissues","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2018-02-13","conditions":"Diabetes, Insulin Resistance, Obesity","enrollment":500},{"nctId":"NCT05831189","phase":"PHASE3","title":"A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2023-04-21","conditions":"Clostridium Difficile Infection Recurrence","enrollment":41},{"nctId":"NCT05248191","phase":"PHASE1","title":"FMT for Postop Crohn's Disease","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2022-04-20","conditions":"Crohn Disease","enrollment":23},{"nctId":"NCT06218602","phase":"PHASE2","title":"Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-02-19","conditions":"Lymphoma","enrollment":40},{"nctId":"NCT07276100","phase":"PHASE2","title":"Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2026-01-01","conditions":"Hepato Cellular Carcinoma (HCC)","enrollment":15},{"nctId":"NCT03829475","phase":"PHASE2","title":"ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-01-01","conditions":"Inflammatory Bowel Diseases, Clostridium Difficile Infection","enrollment":61},{"nctId":"NCT07265817","phase":"NA","title":"Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms","status":"NOT_YET_RECRUITING","sponsor":"Kyungpook National University Hospital","startDate":"2025-12-01","conditions":"Carbapenem-Resistant Enterobacteriaceae Colonization","enrollment":60},{"nctId":"NCT04924270","phase":"PHASE2","title":"Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2023-12-13","conditions":"Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis","enrollment":200},{"nctId":"NCT05533983","phase":"NA","title":"FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2023-03-08","conditions":"Solid Carcinoma","enrollment":50},{"nctId":"NCT07261826","phase":"","title":"Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics","status":"RECRUITING","sponsor":"Chen QiYi","startDate":"2025-09-01","conditions":"Clostridium Difficile Infection Recurrence, Ulcerative Colitis (UC), Crohn Disease (CD)","enrollment":4000},{"nctId":"NCT03819803","phase":"PHASE3","title":"Fecal Microbiota Transplantation in aGvHD After ASCT","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2017-03-01","conditions":"Graft Versus Host Disease in GI Tract","enrollment":15},{"nctId":"NCT06692361","phase":"NA","title":"Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder","status":"RECRUITING","sponsor":"Gang Wang","startDate":"2025-01-01","conditions":"Major Depressive Disorder (MDD), Depression - Major Depressive Disorder","enrollment":214},{"nctId":"NCT06659588","phase":"","title":"Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-10-10","conditions":"Humoral Primary Immunodeficiencies (PIDs), Secondary Form of Humoral Immunodeficiencies, Combined Immunodeficiency (CID)","enrollment":120},{"nctId":"NCT07240181","phase":"","title":"OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity","status":"NOT_YET_RECRUITING","sponsor":"Andreas Munk Petersen","startDate":"2025-12-01","conditions":"IBD (Inflammatory Bowel Disease), Crohns Disease, Colitis Ulcerative","enrollment":40},{"nctId":"NCT02269150","phase":"PHASE2","title":"Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-10","conditions":"Allogeneic Hematopoietic Stem Cell","enrollment":59},{"nctId":"NCT06206707","phase":"NA","title":"FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-01-23","conditions":"Diarrhea, Colitis, Malignant Melanoma","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":567,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Fecal microbial transplantation"],"phase":"phase_3","status":"active","brandName":"Fecal transplantation","genericName":"Fecal transplantation","companyName":"Bogomolets National Medical University","companyId":"bogomolets-national-medical-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fecal microbiota transplantation restores a healthy gut microbiome by transferring bacterial communities from a healthy donor to a patient with dysbiosis. Used for Clostridioides difficile infection (recurrent or refractory), Inflammatory bowel disease (Crohn's disease, ulcerative colitis).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}